Target | cis/trans | Study | SNP | SNP location | Maj/min allele | MAF | N | βinv | seinv | Pinv | fclog | Plog | Praw |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ECM1 | cis | Discovery | rs12724450 | 1:150,480,571 | G/A | 0.09 | 996 | 0.544 | 0.076 | 1.6×10-12 | 1.070 | 5.2×10-10 | 1×10-11 |
ECM1 | cis | Replication | rs34001546 | 1:150,459,715 | A/G | 0.05 | 337 | 0.292 | 0.162 | 0.072 | 1.040 | 0.174 | 0.178 |
Target (abbrv.) | ECM1 |
Target (full name) | Extracellular matrix protein 1 |
Somalogic ID (Sequence ID) | SL006550 (3366-51_2) |
Entrez Gene Symbol | ECM1 |
UniProt ID | Q16610 |
UniProt Comment |
|
Biomarker applications (based on IPA annotation) |
|
All locus annotations are based on the sentinel SNP (rs12724450) and 69 proxy variant(s) that is/are in linkage disequilibrium r2 ≥ 0.8. Linkage disequilibrium is based on data from the 1000 Genomes Project, phase 3 version 5, European population and was retrieved using SNiPA's Block Annotation feature.
Download the detailed results of SNiPA's block annotation (PDF)
Genes hit or close-by |
|
Potentially regulated genes |
|
eQTL genes |
|
Trait | P | Study | Source |
---|---|---|---|
cg16386293 (chr1:150480832) | 7.5×10-109 | 10.1101/033084 (DOI) | BIOS QTL cis-meQTLs |
cg03763518 (chr1:150245020) | 6.6×10-22 | 10.1101/033084 (DOI) | BIOS QTL cis-meQTLs |
cg08856268 (chr1:150436971) | 2×10-10 | 10.1101/033084 (DOI) | BIOS QTL cis-meQTLs |
cg03851496 (chr1:150488781) | 2.6×10-7 | 10.1101/033084 (DOI) | BIOS QTL cis-meQTLs |
Hip circumfence | 6.9×10-7 | 25673412 (PMID) | Supplemental file |
Hip circumfence, adjusted for BMI | 1.9×10-6 | 25673412 (PMID) | Supplemental file |
Waist-to-hip ratio, adjusted for BMI | 5.8×10-6 | 25673412 (PMID) | Supplemental file |
Serum ratio of (biliverdin)/(pyruvate) | 3.1×10-5 | 21886157 (PMID) | GRASP2 metabQTL |
Serum concentration of creatine | 3.9×10-5 | 21886157 (PMID) | GRASP2 metabQTL |
Gene expression of MCL1 in blood | 5.2×10-5 | 21829388 (PMID) | GRASP2 eQTL |
Serum ratio of (1-eicosadienoylglycerophosphocholine*)/(biliverdin) | 1.3×10-4 | 21886157 (PMID) | GRASP2 metabQTL |
Gene expression of C1orf54 [probe ILMN_4355] in osteoblasts treated with BMP2 | 1.5×10-4 | 21283786 (PMID) | GRASP2 eQTL |
Heart rate | 2.9×10-4 | 23583979 (PMID) | GRASP2 nonQTL |
Serum ratio of (eicosapentaenoate (EPA; 20:5n3))/(phenylacetate) | 3.3×10-4 | 21886157 (PMID) | GRASP2 metabQTL |